EP2893922
Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.1.2015EP published:
14.7.2021EP application number:
15150623.5
EPO information:
European Patent Register
Max expiry date:
8.1.2035
Title:
Pharmaceutical formulations for the treatment of pulmonary arterial hypertension
Timeline
Today
9.1.2015EP application
14.7.2021EP Publication
Owner
Name:
Heart Biotech Pharma LimitedAddress:
17 North Drive, Littleton, Winchester SO22 6QA, GB
Inventor
Name:
Yacoub, MagdiAddress:
London, WC1N 2EB, GB
Name:
El Sherbiny, IbrahimAddress:
12588 6th of October City, EG
Priority
Number:
201400412Date:
10.1.2014Country:
GB
Classification
Categories:
A61K 9/50, A61K 9/51, A61K 9/19, A61K 31/12, A61K 31/4965, A61K 31/5575, A61K 33/00, A61P 9/12, A61P 11/00